Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Manchester Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Oxford Featured PhD Programmes
Coventry University Featured PhD Programmes
University of Reading Featured PhD Programmes
"colorectal" AND "cancer"…×
10 miles

colorectal cancer PhD Projects, Programs & Scholarships

We have 20 colorectal cancer PhD Projects, Programs & Scholarships

  • "colorectal" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 10 of 20
  Vitamin C microbubbles as therapeutic agents for colorectal cancer
  Prof SD Evans
Application Deadline: 7 January 2019
Recent published studies have shown that Vitamin C can target and kill colorectal cancer cells that contain gene mutations that are present in approximately 50% of colorectal cancer tumours.
  MRC Precision Medicine DTP: Trascriptome-wide association analysis of survival in colorectal cancer patients
  Prof M Dunlop, Dr E Theodoratou, Dr M Timofeeva
Application Deadline: 7 January 2019
Background. Colorectal cancer (CRC) is the second most common cause of cancer death in UK with 15,900 CRC deaths in 2014. The risk of recurrence and death depends very much on the stage of disease at the time of diagnosis with 5-year survival rate >90% for stage I and.
  PhD studentship in oncolytic virotherapy and cancer immunology: Establishing a potent immuno-oncolytic virotherapy for colorectal cancer.
  Dr A Parker, Prof A Gallimore, Dr A Godkin
Application Deadline: 1 February 2019
An exciting, fully funded PhD studentship opportunity. working at the interface between oncolytic virotherapy and cancer immunotherapy to develop a refined, tumour targeted “immunovirotherapy” suitable for colorectal cancer treatment.
  Defining the role of mitochondrial dysfunction in therapy resistance inKRAS mutant colorectal cancer models
  Research Group: Centre for Cancer Research and Cell Biology
  Dr E Kerr, Dr I Mills, Dr M Wilson
Application Deadline: 20 January 2019
Mutant KRAS driven metabolic reprogramming is a key hallmark of cancer, providing the building blocks necessary to support aberrant cancer cell proliferation and is often achieved through rewiring glycolytic, mitochondrial and fatty acid metabolism, reportedly leading to mitochondrial dysfunction.
  Stratification of colorectal cancer using a combination of molecular biology and digital pathology
  Research Group: Centre for Cancer Research and Cell Biology
  Dr P Dunne, Prof D Longley, Dr M Loughrey
Application Deadline: 20 January 2019
Colorectal cancer (CRC) has one of the highest worldwide incidences (>1.3 million new cases), which results in ~610,000 deaths annually.
  Tumour microenvironment and colorectal cancer development: understanding the mechanisms of the tumour growth
  Prof D Kerr, Dr S Cai
Application Deadline: 11 January 2019
Our group has conducted a series of international adjuvant trials of chemotherapy for colorectal cancer (Kerr RS. et al, (2016), Lancet Oncol, 17, 1543 – 1557).
  Exploration of 5-fluorouracil resistance mechanisms in colorectal cancer using 5-FU-resistant xenograft models
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Dr C Sutton
Applications accepted all year round
Despite therapeutic advances, colorectal cancer (CRC) still has a 45% mortality rate, and one of the major problems is the development of acquired resistance to treatment with anticancer drugs.
  PhD in Cancer & Genetics - Targeting intestinal cancer using 3D organoid cell models
  Prof J R Sampson, Dr L Thomas
Application Deadline: 27 February 2019
Over one million new cases of colorectal cancer (CRC) are diagnosed worldwide each year. Inherited factors appear to be involved in up to 35% of cases.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard, Prof G. McArthur
Applications accepted all year round
Targeted therapy has had profound impact on outcomes for cancer patients.
  Cytochromes P450 in Cancer: Opportunities for Development of Personalised Medicine - Project 1
  Research Group: Institute of Cancer Therapeutics
  Dr K Pors, Prof P Loadman
Applications accepted all year round
The improved understanding of cancer biology provides opportunities for the development of molecular targeted therapies.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.